N-Succinyl-(β-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin : An extracellularly tumor-activated prodrug devoid of intravenous acute toxicity
In: Journal of medicinal chemistry (Print), Jg. 44 (2001), Heft 22, S. 3750-3753
academicJournal
- print, 13 ref
Zugriff:
Intravenous administration of N-(β-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin (4) induces an acute toxic reaction, killing animals in a few minutes. This results from its positive charge at physiological pH combined with its propensity to form large aggregates in aqueous solutions. Negatively charged N-capped versions of 4 such as the succinyl derivative 5 can be administered by the iv route at more than 10 times the LD50 of doxorubicin without inducing the acute toxic reaction, and they are active in vivo.
Titel: |
N-Succinyl-(β-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin : An extracellularly tumor-activated prodrug devoid of intravenous acute toxicity
|
---|---|
Autor/in / Beteiligte Person: | FERNANDEZ, Anne-Marie ; VAN DERPOORTEN, Kim ; TROUET, André ; DASNOIS, Luc ; LEBTAHI, Karim ; DUBOIS, Vincent ; LOBL, Thomas J ; GANGWAR, Sanjeev ; OLIYAI, Cecilia ; LEWIS, Evan R ; SHOCHAT, Dan |
Link: | |
Zeitschrift: | Journal of medicinal chemistry (Print), Jg. 44 (2001), Heft 22, S. 3750-3753 |
Veröffentlichung: | Washington, DC: American Chemical Society, 2001 |
Medientyp: | academicJournal |
Umfang: | print, 13 ref |
ISSN: | 0022-2623 (print) |
Schlagwort: |
|
Sonstiges: |
|